ResearcherThe University of TokyoActive in the last 2 years

Kenzaburo Tani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3335-6188; OpenAlex author ID A5017716828. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts. Last author DOI 10.21873/anticanres.17348 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hisanobu Ogata · 1 shared paper, 2024 · strength 0.20
- Paper A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated … DOI 10.21873/anticanres.17348 ↗
Masafumi Nakamura · 1 shared paper, 2024 · strength 0.20
- Paper A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated … DOI 10.21873/anticanres.17348 ↗
Hideya Onishi · 1 shared paper, 2024 · strength 0.20
- Paper A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated … DOI 10.21873/anticanres.17348 ↗
Akira Imaizumi · 1 shared paper, 2024 · strength 0.20
- Paper A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated … DOI 10.21873/anticanres.17348 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.